Global Health Research Center, Duke Kunshan University, No. 8 Duke Avenue, Kunshan, 215316, Jiangsu, China.
Department of Public Health, University of Muhammadiyah Prof DR Hamka, South Jakarta, Indonesia.
BMC Public Health. 2022 Apr 8;22(1):689. doi: 10.1186/s12889-022-13017-y.
Indonesia suffers from a high burden of tuberculosis (TB) and diabetes (DM). The government initiated national TB-DM co-management activities under the National TB Control Program in 2017. This study investigates the detection and treatment outcomes of TB-DM in Jakarta after implementing these activities, and identifies the main factors associated with these outcomes.
A cross-sectional study was conducted using TB registry data in two districts of Jakarta, East Jakarta (low-income) and South Jakarta (high-income). A 5-step cascade analysis was used: diagnosed TB patients; TB patients tested for DM; diagnosed TB-DM patients; and patients received and completed TB treatment/cured. We conducted descriptive analyses to understand the characteristics of TB and TB-DM patients, and used a two-level mixed-effect logistic regression to explore factors associated with having a DM test and completing TB treatment/being cured.
Over the study period (2017-2019) 50.8% of the new pulmonary TB patients aged over 15 were tested for DM. The percentage increased from 41.7% in 2017-2018 to 60.1% in 2019. Of the TB patients tested for DM, 20.8% were diagnosed with DM. Over 90% of the detected TB-DM patients received standard TB treatment, 86.3% of whom completed treatment/were cured. Patients in East Jakarta were more likely to be tested for DM and to complete standard TB treatment/be cured than patients in South Jakarta (P < 0.001). Bacteriologically positive TB patients were more likely to be tested for DM (OR = 1.37, 95% CIs 1.17,1.60). Patients diagnosed in sub-district level healthcare centers had a higher likelihood of being tested for DM than those in government and private hospitals (P < 0.05). Receiving DM treatment was associated with a higher likelihood of completing TB treatment/being cured (OR = 1.82, 95% CIs 1.20, 2.77).
TB-DM case detection significantly improved in 2019 after introducing TB-DM co-management activities in Jakarta, while gaps in TB-DM co-management existed between bacteriologically positive and clinically diagnosed TB patients, and across different types of health facilities. Collaboration between TB and DM departments should be strengthened, and more resources need to be mobilized to further improve the co-management of TB-DM in Indonesia.
印度尼西亚结核病(TB)和糖尿病(DM)负担沉重。政府于 2017 年在国家结核病控制计划下启动了国家结核病-糖尿病共同管理活动。本研究调查了在雅加达实施这些活动后结核病-糖尿病的检测和治疗结果,并确定了与这些结果相关的主要因素。
使用雅加达两个区(东雅加达(低收入)和雅加达南部(高收入))的结核病登记数据进行了横断面研究。采用 5 步级联分析:诊断为结核病的患者;接受 DM 检测的结核病患者;诊断为结核病-糖尿病的患者;接受并完成结核病治疗/治愈的患者。我们进行了描述性分析,以了解结核病和结核病-糖尿病患者的特征,并使用两级混合效应逻辑回归模型探讨与接受 DM 检测和完成结核病治疗/治愈相关的因素。
在研究期间(2017-2019 年),50.8%的 15 岁以上新肺结核患者接受了 DM 检测。这一比例从 2017-2018 年的 41.7%上升到 2019 年的 60.1%。在接受 DM 检测的结核病患者中,20.8%被诊断患有 DM。超过 90%的确诊结核病-糖尿病患者接受了标准结核病治疗,其中 86.3%完成了治疗/治愈。与雅加达南部的患者相比,东雅加达的患者更有可能接受 DM 检测和完成标准结核病治疗/治愈(P<0.001)。菌阳结核病患者更有可能接受 DM 检测(OR=1.37,95%CI 1.17,1.60)。在基层医疗中心诊断的患者比在政府和私人医院就诊的患者更有可能接受 DM 检测(P<0.05)。接受 DM 治疗与完成结核病治疗/治愈的可能性更高相关(OR=1.82,95%CI 1.20,2.77)。
在雅加达引入结核病-糖尿病共同管理活动后,2019 年结核病-糖尿病病例检出率显著提高,然而,在菌阳和临床诊断结核病患者之间,以及在不同类型的卫生机构之间,结核病-糖尿病共同管理仍存在差距。应加强结核病和糖尿病部门之间的合作,并调动更多资源,以进一步改善印度尼西亚结核病-糖尿病的共同管理。